Income as of third quarter of 2018 per following table: (THB) Million 3Q18 3Q17 9M18 9M17 Total Revenues 124.06 143.81 392.98 412.86 Total Expenses 120.70 128.25 365.21 373.13 Shares of Profits 6.01 13.81
of bank loans for the acquisition of the remaining shares of the subsidiary. Page 3 of 4 Net Profits The consolidated profit before non-controlling interest of 2Q’18 decreased by 10% yoy despite the
subsidiary. Net Profits The consolidated profit before non-controlling interest of 3Q’18 increased by 1% yoy. The slight increase of net profit despite high growth of income was primarily due to lower gross
accounted for 4.4 – 9.6 percent of the total revenues, and the gross operating profits from the manufacturing business accounted for 1 – 5 percent of the total gross operating profits, and as such, the
statements, use NTA from consolidated financial statements (data should be extracted from the latest financial statements) NA Calculation based on net operating profits (Net operating profits of the investment
Esthetics under Trademark “Wuttisak” Attn. to: President The Stock Exchange of Thailand Refer to: Letter of FVC Ref. No. SET-2560-025 “Transaction to Acquire Franchise Wuttisak 25 Branches from Total 113
รายงานการประชุมคณะกรรมการตรวจสอบ ครั้งที่ 4/2548 Ref.: SET-2018-002 February 9, 2018 Subject: Signing on the Franchise Agreement; and the Agreement to Acquire and Dispose Assets of “Wuttisak Clinic
Target’s shares, the Company will acquire a total of 88,120,190 shares, equivalent to 80.11 percent of the total paid-up shares of the Target, at the offer price of Baht 15.70 per share, equivalent to a
Company’s conditional voluntary tender offer for all Target’s shares, the Company will acquire a total of 88,120,190 shares, equivalent to 80.11 percent of the total paid-up shares of the Target, at the offer
the Target accept the Company’s conditional voluntary tender offer for all Target’s shares, the Company will acquire a total of 88,120,190 shares, equivalent to 80.11 percent of the total paid-up shares